Skip to main content

Table 2 Patient characteristics at enrolment date

From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Patient characteristic CKD 1–3 (n = 64) CKD 4–5 (n = 55) Dialysis (n = 61) Transplant (n = 63) P value
Country, n (%)a      <0.0001
 Denmark 26 (41) 32 (58) 32 (52) 28 (44)  
 Sweden 19 (30) 12 (22) 14 (23) 13 (21)  
 Norway 19 (30) 11 (20) 4 (7) 16 (25)  
 Finland 0 (0) 0 (0) 11 (18) 6 (10)  
Sex (female), n (%) 38 (59) 29 (53) 33 (54) 31 (49) 0.7144
Age (years), mean ± SDb 52 ± 13 57 ± 12 64 ± 10 59 ± 10 <0.0001
BMI (≥30 kg/m2), n (%) 10 (16) 11 (20) 15 (25) 14 (22) 0.7667
Currently employed, n (%) 40 (63) 27 (49) 13 (21) 28 (44) <0.0001
Currently employed (aged <65 years), n (%) 40 (78) 27 (64) 12 (38) 26 (59) <0.0001
Comorbidities (≥1), n (%) 43 (67) 44 (80) 61 (100) 45 (76) <0.0001
Dialysis in the past 12 months, n (%) a . . 61 (100) 5 (8) <0.0001
 Haemodialysis . . 51 (84) 5 (100) 1.0000
 Peritoneal dialysis . . 12 (20) 0 (0) 0.5754
  1. P values calculated with χ2 test unless otherwise specified
  2. SD standard deviation, BMI body mass index
  3. aFisher’s exact test
  4. bKruskal–Wallis test